Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Feeling younger can improve health and extend life.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Older men should openly discuss sexual health with doctors to improve their quality of life.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

AGA affects many, progresses differently, and early treatment is crucial.

Analog 23 is a promising compound for prostate cancer treatment.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

5-α-reductase inhibitors don't prevent prostate cancer but may reduce unnecessary biopsies.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Case-only trees and random forests improve predictions of treatment effects in clinical trials.

Higher free testosterone levels can increase bone density and decrease body fat but may raise the risk of prostate cancer, hair loss, and benign prostate enlargement.

Male hormones may make COVID-19 worse, while substances that block these hormones could lessen symptoms.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

Androgen deprivation therapy might help prevent severe COVID-19, but more research is needed.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

Finasteride reduces low-grade prostate cancer but may not be beneficial overall.

Male pattern baldness is common, treatable, and may be linked to heart disease and prostate cancer.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Androgenetic alopecia may indicate higher risk for certain diseases and mental health issues.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.